160 related articles for article (PubMed ID: 28490261)
21. [In vitro effect of vancomycin and daptomycin on biofilm formation of coagulase-negative staphylococci strains].
Öcal DN; Dolapçı İ; Gençtürk Z; Tekeli A
Mikrobiyol Bul; 2017 Jul; 51(3):220-235. PubMed ID: 28929959
[TBL] [Abstract][Full Text] [Related]
22. Vancomycin MIC Does Not Predict 90-Day Mortality, Readmission, or Recurrence in a Prospective Cohort of Adults with Staphylococcus aureus Bacteremia.
Baxi SM; Clemenzi-Allen A; Gahbauer A; Deck D; Imp B; Vittinghoff E; Chambers HF; Doernberg S
Antimicrob Agents Chemother; 2016 Sep; 60(9):5276-84. PubMed ID: 27324762
[TBL] [Abstract][Full Text] [Related]
23. Impact of vancomycin minimum inhibitory concentration on mortality among critically ill patients with methicillin-resistant Staphylococcus aureus bacteremia.
Woods CJ; Chowdhury A; Patel VM; Shorr AF
Infect Control Hosp Epidemiol; 2012 Dec; 33(12):1246-9. PubMed ID: 23143364
[TBL] [Abstract][Full Text] [Related]
24. Daptomycin Improves Outcomes Regardless of Vancomycin MIC in a Propensity-Matched Analysis of Methicillin-Resistant Staphylococcus aureus Bloodstream Infections.
Claeys KC; Zasowski EJ; Casapao AM; Lagnf AM; Nagel JL; Nguyen CT; Hallesy JA; Compton MT; Kaye KS; Levine DP; Davis SL; Rybak MJ
Antimicrob Agents Chemother; 2016 Oct; 60(10):5841-8. PubMed ID: 27431221
[TBL] [Abstract][Full Text] [Related]
25. Methicillin-resistant Staphylococcus aureus (MRSA) staphylococcal cassette chromosome mec genotype effects outcomes of patients with healthcare-associated MRSA bacteremia independently of vancomycin minimum inhibitory concentration.
Chen SY; Liao CH; Wang JL; Chiang WC; Lai MS; Chie WC; Chen WJ; Chang SC; Hsueh PR
Clin Infect Dis; 2012 Nov; 55(10):1329-37. PubMed ID: 22911641
[TBL] [Abstract][Full Text] [Related]
26. Coagulase-negative staphylococcal bloodstream infections: Does vancomycin remain appropriate empiric therapy?
Valencia-Rey P; Weinberg J; Miller NS; Barlam TF
J Infect; 2015 Jul; 71(1):53-60. PubMed ID: 25725152
[TBL] [Abstract][Full Text] [Related]
27. Methicillin-resistant Staphylococcus aureus bacteremia in hemodialysis and nondialysis patients.
Kan LP; Lin JC; Chiu SK; Yeh YC; Lin TY; Yang YS; Wang YC; Wang NC; Yeh KM; Chang FY
J Microbiol Immunol Infect; 2014 Feb; 47(1):15-22. PubMed ID: 23040238
[TBL] [Abstract][Full Text] [Related]
28. Early use of daptomycin versus vancomycin for methicillin-resistant Staphylococcus aureus bacteremia with vancomycin minimum inhibitory concentration >1 mg/L: a matched cohort study.
Murray KP; Zhao JJ; Davis SL; Kullar R; Kaye KS; Lephart P; Rybak MJ
Clin Infect Dis; 2013 Jun; 56(11):1562-9. PubMed ID: 23449272
[TBL] [Abstract][Full Text] [Related]
29. Coagulase-negative Staphylococcus bacteraemia accounts for one third of Staphylococcus bacteraemia in a French university hospital.
N'Guyen Y; Baumard S; Vernet-Garnier V; Batalla AS; de Champs C; Jaussaud R; Strady C
Scand J Infect Dis; 2012 Feb; 44(2):79-85. PubMed ID: 22017739
[TBL] [Abstract][Full Text] [Related]
30. Association between vancomycin minimum inhibitory concentration and mortality among patients with Staphylococcus aureus bloodstream infections: a systematic review and meta-analysis.
Kalil AC; Van Schooneveld TC; Fey PD; Rupp ME
JAMA; 2014 Oct; 312(15):1552-64. PubMed ID: 25321910
[TBL] [Abstract][Full Text] [Related]
31. Antibiotic choice may not explain poorer outcomes in patients with Staphylococcus aureus bacteremia and high vancomycin minimum inhibitory concentrations.
Holmes NE; Turnidge JD; Munckhof WJ; Robinson JO; Korman TM; O'Sullivan MV; Anderson TL; Roberts SA; Gao W; Christiansen KJ; Coombs GW; Johnson PD; Howden BP
J Infect Dis; 2011 Aug; 204(3):340-7. PubMed ID: 21742831
[TBL] [Abstract][Full Text] [Related]
32. Impact of Vancomycin MIC on Treatment Outcomes in Invasive Staphylococcus aureus Infections.
Song KH; Kim M; Kim CJ; Cho JE; Choi YJ; Park JS; Ahn S; Jang HC; Park KH; Jung SI; Yoon N; Kim DM; Hwang JH; Lee CS; Lee JH; Kwak YG; Kim ES; Park SY; Park Y; Lee KS; Lee YS; Kim HB
Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 27956430
[TBL] [Abstract][Full Text] [Related]
33. Vancomycin Trough Concentration as a Predictor of Clinical Outcomes in Patients with Staphylococcus aureus Bacteremia: A Meta-analysis of Observational Studies.
Prybylski JP
Pharmacotherapy; 2015 Oct; 35(10):889-98. PubMed ID: 26497475
[TBL] [Abstract][Full Text] [Related]
34. In vitro efficacy and pharmacodynamic indices for antibiotics against coagulase-negative staphylococcus endophthalmitis isolates.
Harper T; Miller D; Flynn HW
Ophthalmology; 2007 May; 114(5):871-5. PubMed ID: 17383732
[TBL] [Abstract][Full Text] [Related]
35. agr functionality affects clinical outcomes in patients with persistent methicillin-resistant Staphylococcus aureus bacteraemia.
Kang CK; Kim YK; Jung SI; Park WB; Song KH; Park KH; Choe PG; Jang HC; Lee S; Kim YS; Kwak YG; Kwon KT; Kiem S; Kim CJ; Kim ES; Kim HB;
Eur J Clin Microbiol Infect Dis; 2017 Nov; 36(11):2187-2191. PubMed ID: 28639163
[TBL] [Abstract][Full Text] [Related]
36. Comparative effectiveness of linezolid versus vancomycin as definitive antibiotic therapy for heterogeneously resistant vancomycin-intermediate coagulase-negative staphylococcal central-line-associated bloodstream infections in a neonatal intensive care unit.
Blanchard AC; Fortin E; Laferrière C; Goyer I; Moussa A; Autmizguine J; Quach C
J Antimicrob Chemother; 2017 Jun; 72(6):1812-1817. PubMed ID: 28333257
[TBL] [Abstract][Full Text] [Related]
37. Impact of vancomycin MIC creep on patients with methicillin-resistant Staphylococcus aureus bacteremia.
Yeh YC; Yeh KM; Lin TY; Chiu SK; Yang YS; Wang YC; Lin JC
J Microbiol Immunol Infect; 2012 Jun; 45(3):214-20. PubMed ID: 22571999
[TBL] [Abstract][Full Text] [Related]
38. Predictors of persistent methicillin-resistant Staphylococcus aureus bacteraemia in patients treated with vancomycin.
Yoon YK; Kim JY; Park DW; Sohn JW; Kim MJ
J Antimicrob Chemother; 2010 May; 65(5):1015-8. PubMed ID: 20200036
[TBL] [Abstract][Full Text] [Related]
39. Vancomycin MIC as a predictor of outcome in MRSA bacteraemia in the UK context.
Hope R; Blackburn RM; Verlander NQ; Johnson AP; Kearns A; Hill R; Hopkins S; Sheridan E; Livermore DM; ;
J Antimicrob Chemother; 2013 Nov; 68(11):2641-7. PubMed ID: 23794604
[TBL] [Abstract][Full Text] [Related]
40. Clinical characteristics of vancomycin minimum inhibitory concentration of 2 μg/ml methicillin-resistant Staphylococcus aureus strains isolated from patients with bacteremia.
Takesue Y; Nakajima K; Takahashi Y; Ichiki K; Ishihara M; Wada Y; Tsuchida T; Uchino M; Ikeuchi H
J Infect Chemother; 2011 Feb; 17(1):52-7. PubMed ID: 20625789
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]